🟢 Icecure Medical is trading 10.17% up in after-hours trading — no clear late-breaking catalyst identified

Icecure Medical is trading at $1.16, up 10.17%, with no clear late-breaking catalyst identified.

• On October 20, Icecure Medical announced that the first two patients had enrolled in its FDA-approved ChoICE study at U.S. sites; the release came at 7:55 a.m. ET.
• The regular-session close was $1.05, down 2.78%.
• After-hours volume or activity details were unavailable.